Search Results

By Christina Klemm, Pharm.D., BCACP, Senior Pharmacist, Clinical Operations, Enlyte Pharmacy fraud represents one of the fastest-growing cost drivers in workers’ compensation claims. While most health care providers operate with integrity, fraudulent prescribing patterns can […]

By: Christina Klemm, Pharm.D., BCACP, Clinical Operations, Enlyte Morphine Equivalent Dose (MED) is a standardized way to estimate a person's total opioid exposure over a 24-hour period. Because different opioid medications have varying potencies, a common […]

By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte The U.S. Food and Drug Administration (FDA) recently approved Journavx (suzetrigine), a novel non-opioid medication developed by Vertex Pharmaceuticals for the treatment of moderate to severe acute pain in […]

By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte Developed in the 1960s as an anesthetic, ketamine quickly became a staple in emergency and battlefield medicine. Its ability to act as a powerful, rapid-acting anesthetic was […]

By: Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist, Enlyte Pharmacy Solutions Urine drug testing (UDT) plays an important role in workers’ compensation, serving as an essential tool for pharmacy benefit managers (PBMs) to ensure safe and […]

By Christina Klemm, Pharm.D., BCACP, Clinical Pharmacist Recently the U.S. Food and Drug Administration (FDA) approved an over-the-counter (OTC) naloxone hydrochloride nasal spray product for treating opioid overdose. For the first time, medication to reverse […]